Appointment New Patient Appointment or 214-645-8300

Appointment New Patient Appointment or 214-645-8300

More Blogs

MedBlog

Cardiac Surgery

Stereotactic radiation offers new hope for high-risk heart patients

Stereotactic radiation offers new hope for high-risk heart patients

UT Southwestern is the only center in North Texas offering cardiac radioablation, a novel therapy that uses focused stereotactic radiation to assist in cardiac ablation for high-risk patients.

James Daniels, M.D. / Richard Wu, M.D. / Robert Timmerman, M.D.

July 28, 2021

After heart attack, this rare procedure can save patients from a hole in the heart

After heart attack, this rare procedure can save patients from a hole in the heart

VSD, or ventricular septal defect, is a complication in 1/1,000 patients who don't get ER care for a heart attack – and 97% die within a year of suffering this complication. This procedure is the last chance to save their lives.

Anthony Bavry, M.D.

August 19, 2020

Tragic trifecta: Coronavirus, heart attacks, and empty ERs

Tragic trifecta: Coronavirus, heart attacks, and empty ERs

Fear of COVID-19 in the ER has led to fewer visits for heart attack symptoms. Unfortunately, the virus itself can cause severe heart damage. Do not ignore chest pains, especially during the pandemic. Get the facts in this week's MedBlog.

Joseph A. Hill, M.D., Ph.D.

April 30, 2020

10 questions to test your heart-health knowledge

10 questions to test your heart-health knowledge

How much do you know about heart disease risks? Take this 5-minute quiz to find out what you know – and don't – about heart health.

Amit Khera, M.D.

February 13, 2020

Medication as effective as stents, bypass for treating blocked arteries, major study shows

Medication as effective as stents, bypass for treating blocked arteries, major study shows

A landmark study has confirmed that, in certain patients with chest pain and abnormal stress tests, drug therapy can be just as effective as bypass or stents to prevent heart attack. In this MedBlog, James De Lemos, M.D., discusses how the findings can help patients save time and money, plus reduce unnecessary risks.

James de Lemos, M.D.

February 5, 2020

New drugs for cardiac amyloidosis provide hope for patients

New drugs for cardiac amyloidosis provide hope for patients

For decades, there were no FDA-approved treatments for cardiac amyloidosis in the U.S. But in the last two years, two new therapies were approved for cardiac- and nerve-related ATTR. In this week's MedBlog, Justin Grodin, M.D., discusses these therapies and what they mean for North Texas patients.

Justin Grodin, M.D., M.P.H.

July 31, 2019